Programmbereich Infektionen

Klinische Infektiologie

Mission    Projekte    Drittmittel    Methoden    Publikationen    Mitarbeiter/innen

Publikationen

2018

Alastruey-Izquierdo A, Cadranel J, Flick H, Godet C, Hennequin C, Hoenigl M, Kosmidis C, Lange C, Munteanu, O, Page I, Salzer HJF on behalf of CPAnet. Treatment of Chronic Pulmonary Aspergillosis: Current Standards and Future Perspectives. Respiration. 2018 Jul 6:1-12. doi: 10.1159/000489474. PMID 29982245

Dalhoff K, Abele-Horn M, Andreas S, Deja M, Ewig S, Gastmeier P, Gatermann S, Gerlach H, Grabein B, Heußel CP, Höffken G, Kolditz M, Kramme E, Kühl H, Lange C, Mayer K, Nachtigall I, Panning M, Pletz M, Rath PM, Rohde G, Rosseau S, Schaaf B, Schreiter D, Schütte H, Seifert H, Spies C, Welte T; Unter Mitwirkung der folgenden Wissenschaftlichen Fachgesellschaften und Institutionen: Deutsche Gesellschaft für Chirurgie; Deutsche Gesellschaft für Innere Medizin e. V; Deutsche Gesellschaft für Internistische Intensivmedizin und Notfallmedizin; Deutsche Sepsis-Gesellschaft e. V; und Robert Koch-Institut. [Epidemiology, Diagnosis and Treatment of Adult Patients with Nosocomial Pneumonia - Update 2017 - S3 Guideline of the German Society for Anaesthesiology and Intensive Care Medicine, the German Society for Infectious Diseases, the German Society for Hygiene and Microbiology, the German Respiratory Society and the Paul-Ehrlich-Society for Chemotherapy, the German Radiological Society and the Society for Virology]. Pneumologie. 2018 Jan;72(1):15-63. doi: 10.1055/s-0043-121734. Epub 2018 Jan 16. German. PubMed PMID: 29341032

Denning DW, Page ID, Chakaya J, Jabeen K, Jude CM, Cornet M, Alastruey-Izquierdo A, Bongomin F, Bowyer P, Chakrabarti A, Gago S, Guto J, Hochhegger B, Hoenigl M, Irfan M, Irurhe N, Izumikawa K, Kirenga B, Manduku V, Moazam S, Oladele RO, Richardson MD, Tudela JLR, Rozaliyani A, Salzer HJF, Sawyer R, Simukulwa NF, Skrahina A, Sriruttan C, Setianingrum F, Wilopo BAP, Cole DC, Getahun H. Case Definition of Chronic Pulmonary Aspergillosis in Resource-Constrained Settings. Emerg Infect Dis. 2018 Aug;24(8). doi: 10.3201/eid2408.171312. PubMed PMID: 30016256; PubMed Central PMCID: PMC6056117.


Dheda K, Cox H, Esmail A, Wasserman S, Chang KC, Lange C. Recent controversies about MDR and XDR-TB: Global implementation of the WHO shorter MDR-TB regimen and bedaquiline for all with MDR-TB? Respirology. 2018 Jan;23(1):36-45. doi: 10.1111/resp.13143. Epub 2017 Aug 29. Review. PMID: 28850767

Dheda K, Gumbo T, Lange C, Horsburgh Jr CR, Furin J. Pan-tuberculosis regimens: an argument against. Lancet Respir Med. 2018 Apr;6(4):240-242. doi: 10.1016/S2213-2600(18)30097-3. PMID: 29595502

Donald PR, Diacon AH, Lange C, Demers AM,  von Groote-Bidlingmaier F, Nardell EA. Droplets, dust and guinea pigs; an historical review of tuberculosis transmission research; 1878-1940. Int J Tuberc Lung Dis 2018; 22(9), 1 September: 972-982(11) doi.org/10.5588/ijtld.18.0173 PMID: 30092861

Dudnyk A, Chesov D, Lange C. Mission impossible: The EndTB Strategy. Int J Tuberc Lung Dis. 2018 Feb 1;22(2):121-122. doi: 10.5588/ijtld.17.0842. No abstract available. PMID: 29506606

Ezewudo M, Borens A, Chiner-Oms Á, Miotto P, Chindelevitch L, Starks AM, Hanna D, Liwski R, Zignol M, Gilpin C, Niemann S, Kohl TA, Warren RM, Crook D, Gagneux S, Hoffner S, Rodrigues C, Comas I, Engelthaler DM, Alland D, Rigouts L, Lange C, Dheda K, Hasan R, McNerney R, Cirillo DM, Schito M, Rodwell TC, Posey J. Sci Rep. 2018 Oct 18;8(1):15382. doi: 10.1038/s41598-018-33731-1. PMID: 30337678

Godet C, Alastruey-Izquierdo A, Flick H, Hennequin C, Mikilps-Mikgelbs R, Munteanu O, Page I, Seidel D, Salzer HJF; CPAnet. A CPAnet consensus statement on research priorities for chronic pulmonary aspergillosis: a neglected fungal infection that requires attention. J Antimicrob Chemother. 2018 Feb 1;73(2):280-286. doi: 10.1093/jac/dkx390. PubMed PMID: 29126309.

Griffith DE, Eagle G, Thomson R, Aksamit TR, Hasegawa N, Morimoto K, Addrizzo-Harris DJ, O'Donnell AE, Marras TK, Flume PA, Loebinger MR, Morgan L, Codecasa LR, Hill AT, Ruoss SJ, Yim JJ, Ringshausen FC, Field SK, Philley JV, Wallace RJ Jr, van Ingen J, Coulter C, Nezamis J, Winthrop KL; CONVERT Study Group. Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by Mycobacterium avium Complex (CONVERT): A Prospective, Open-Label, Randomized Study. Am J Respir Crit Care Med. 2018 Sep 14. doi: 10.1164/rccm.201807-1318OC. PMID: 30216086

Gröschel MI, Walker TM, van der Werf TS, Lange C, Niemann S, Merker M. PLoS Pathog. 2018 Oct 18;14(10):e1007297. doi: 10.1371/journal.ppat.1007297. PMID: 30335850

Guglielmetti L, Tiberi S, Burman M, Kunst H, Wejse C, TogonidzeT, Bothamley G, Lange C for the TBNET* (* additional collaborators of the TBNET: Hafizi H, Kirakosyan O, Rumetshofer R, Skrahina A, Muylle I, Zutic H, Markova R, Jankovic M, Gyorfy Z, Georgios G, Bengård Andersen A, Ravn P, Kolekar S, Danilovits M, Vasankari T, Fréchet-Jachym M,  Kiria N, Avaliani Z, Wetzstein N, Korkut Avsar K, Dimopoulos G, Horvath I, Kristjánsson M, McLaughlin AM, Chiappini E, Confalonieri M, Del Bravo, P Gualano G, Motta I, Pontali E, Tunesi  S, Kurhasani X, Kuksa L, Jacunskiene L, Wirtz Gil G, Nanovikj Z, Dumitru Chesov D, Bojovic  O , de Lange W, Magis-Escurra C, van Ingen J, Jensenius M, Kruczak K, Duarte R, Mihaescu T, Ibraim E, Kaluzhenina A, Volchenkov G, Pesut D, Ivan Solovic I, García-García JM, Luque-Márquez RM, Sánchez-Montalvá A, de Souza Galvao ML, Norrby M, Schoch O, Dudnyk A, Belton M, Martin Dedicoat M). QT prolongation and cardiac toxicity of new tuberculosis drugs in Europe: A Tuberculosis Network European Trialsgroup (TBnet) study. Eur Respir J. 2018 Jun 7. pii: 1800537. doi: 10.1183/13993003.00537-2018. PMID: 29880656

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Danilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Popa C, Rudolf Rumetshofer, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C. Clinical management of multidrug-resistant tuberculosis in 16 European countries. Am J Respir Crit Care Med. 2018 Mar 6. doi: 10.1164/rccm.201710-2141OC. PMID: 29509468

Hargreaves S, Nellums LB, Ravensbergen SJ, Friedland JS, Stienstra Y, on behalf of the ESCMIT Working Group On Vaccination In Migrants (Beeching N, Castelli F, Carballo M, Norredam M, Leblebicioglu H, Erdem H, Carballo M, Lange C, Goletti D, Wejse C, Ozaras R, Lopez-Velez R, Tsakris A, Petersen E, Civljak R, Schlagenhauf P, Vignier N.). Divergent approaches in the vaccination of recently arrived migrants to Europe: a survey of national experts from 32 countries, 2017. Euro Surveill. 2018 Oct;23(41). doi: 10.2807/1560-7917.ES.2018.23.41.1700772. PMID: 30326996.

Heyckendorf J, Andres S, Köser CU, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. What Is Resistance? Impact of Phenotypic versus Molecular Drug Resistance Testing on Therapy for Multi- and Extensively Drug-Resistant Tuberculosis. Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01550-17. doi: 10.1128/AAC.01550-17. Print 2018 Feb. PMID: 29133554

Heyckendorf  J, van Leth F, Avsar K, Glattki G, Günther G, Kalsdorf B, Müller M, Olaru ID, Rolling T, Salzer HJF, Schuhmann M, Terhalle E, Lange C. Treatment responses in multidrug-resistant tuberculosis in Germany. Int J Tuberc Lung Dis. 2018 Apr 1;22(4):399-406. doi: 10.5588/ijtld.17.0741. PMID: 29562987 (IF 2.4)

Heyckendorf J, van Leth F, Kalsdorf B, Olaru ID, Günther G, Salzer HJF, Terhalle E, Rolling TE, Glattki G, Müller M, Schuhmann M, Avsar K, Lange C. Relapse-free cure from multidrug-resistant tuberculosis in Germany. Eur Respir J. 2018 Feb 21;51(2). pii: 1702122. doi: 10.1183/13993003.02122-2017. Print 2018 Feb. No abstract available. PMID: 29467205

Jafari C, Olaru ID, Daduna F, Ernst M, Heyckendorf J, Lange C, Kalsdorf B. Rapid diagnosis of pulmonary tuberculosis by combined molecular and immunological methods. Eur Respir J. 2018 Mar 29. pii: 1702189. doi: 10.1183/13993003.02189-2017. PubMed PMID: 29599184.

Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M. Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy. Drug Des Devel Ther. 2018 Apr 30;12:1033-1044. doi: 10.2147/DDDT.S145545. eCollection 2018. Review. PubMed PMID: 29750016


Köser CU, Heyckendorf J, Andres S, Olaru ID, Schön T, Sturegård E, Beckert P, Schleusener V, Kohl TA, Hillemann D, Moradigaravand D, Parkhill J, Peacock SJ, Niemann S, Lange C, Merker M. 2018. Reply to Dookie et al., “Whole-genome sequencing to guide the selection of treatment for drugresistant tuberculosis.” Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00616-18. doi: 10.1128/AAC.00616-18. Print 2018 Aug. PMID: 30054377

Lange C, Chesov D, Furin J, Udwadia Z, Dheda K. Revising the definition for extensively drug-resistant tuberculosis (XDR-TB). The Lancet Respir Med. 2018 Published online November 9, 2018 http://dx.doi.org/10.1016/S2213-2600(18)30428-4  PMID: 30420247

Lange C, Alghamdi WA, Al-Shaer MH, Brighenti S, Diacon AH, DiNardo AR, Grobbel HP, Gröschel MI, von Groote-Bidlingmaier F, Hauptmann M, Heyckendorf J, Köhler N, Kohl TA, Merker M, Niemann S, Peloquin CA, Reimann M, Schaible UE, Schaub D, Schleusener V, Thye T, Schön T. Perspectives for personalized therapy for patients with multidrug-resistant tuberculosis. J Intern Med. 2018 May 28. doi: 10.1111/joim.12780. [Epub ahead of print] Review. PMID: 29806961

Lange C, Chesov D, Heyckendorf J, Leung CC, Udwadia Z, Dheda D. Drug-resistant tuberculosis: an update on disease burden, diagnosis, and treatment. Respirology. 2018 Apr 11. doi: 10.1111/resp.13304. PMID: 29641838

Lange C, van Leth F, Mitnick CD, Dheda K, Günther G. Time to revise the WHO recommended definitions of MDR-TB treatment outcomes. Lancet Respir Med. 2018 Apr;6(4):246-248. doi: 10.1016/S2213-2600(18)30104-8. PMID: 29595505

Lange C, Chesov D, Heyckendorf J. Clofazimine for the treatment of multidrug-resistant tuberculosis. Clin Microbiol Infect. 2018 Nov 22. pii: S1198-743X(18)30737-7. doi: 10.1016/j.cmi.2018.11.010. PMID: 30472423

Olaru ID, Van Den Broucke S, Rosser AJ, Salzer HJF, Woltmann G, Bottieau E, Lange C. Pulmonary Diseases in Refugees and Migrants in Europe. Respiration. 2018 Feb 7. doi: 10.1159/000486451. [Epub ahead of print] PMID: 29414830

Radloff J, Heyckendorf J, van der Merwe L, Sanchez-Carballo P, Reiling N, Richter E, Lange C, Kalsdorf B. Mycobacterium growth inhibition assay of human alveolar macrophages as a correlate of immune protection following M. bovis BCG-vaccination. Front Immunol. 2018 Jul 24;9:1708. doi: 10.3389/fimmu.2018.01708. eCollection 2018. PMID: 30087678

Ravensbergen SJ, Nellums LB, Hargreaves S, Stienstra Y, Friedland JS; ESGITM Working Group on Vaccination in Migrants (Beeching N, Castelli F, Carballo M, Norredam M, Leblebicioglu H, Erdem H, Carballo M, Lange C, Goletti D, Wejse C, Ozaras R, Lopez-Velez R, Tsakris A, Petersen E, Civljak R, Schlagenhauf P, Vignier N.); with the support of the Executive Committee and Membership of ESGITM. National approaches to the vaccination of recently arrived migrants in Europe: A  comparative policy analysis across 32 European countries. Travel Med Infect Dis. 2018 Oct 15. pii: S1477-8939(18)30366-1. doi: 10.1016/j.tmaid.2018.10.011. PMID: 30336255  

Salzer HJF, Burchard G, Cornely OA, Lange C, Rolling T, Schmiedel S, Libman M, Capone D, Le T, Dalcolmo MP, Heyckendorf J. Diagnosis and Management of Systemic Endemic Mycoses Causing Pulmonary Disease. Respiration. 2018 Jun 28:1-19. doi: 10.1159/000489501. [Epub ahead of print] PMID: 29953992

Salzer HJF, Prattes J, Flick H, Reimann M, Heyckendorf J, Kalsdorf B, Obersteiner S, Gaede KI, Herzmann C, Johnson GL, Lange C, Hoenigl M. Front Microbiol. 2018 Oct 2;9:2223. doi: 10.3389/fmicb.2018.02223. eCollection 2018. PMID: 30333797

Salzer HJF, Schäfer G, Hoenigl M, Günther G,  Hoffmann C, Kalsdorf B,  Alanio A, Lange C. Clinical, diagnostic and treatment disparities between HIV-infected and non-HIV-infected immunocompromised patients with Pneumocystis jirovecii pneumonia. Respiration 2018 Apr 10. doi: 10.1159/000487713. PMID 29635251

Salzer HJF, Stoney RJ, Angelo KM, Rolling T, P. Grobusch MP, Libman M, López-Vélez R, Duvignaud A, Ásgeirsson H, Crespillo-Andújar C, Schwartz E, Gautret P, Bottieau E, Jordan S, Lange C, Hamer DH, for the GeoSentinel Surveillance Network. Epidemiological aspects of travel-related systemic endemic mycoses: a GeoSentinel analysis, 1997–2017. J Travel Med. 2018 Aug 1;25(1). doi: 10.1093/jtm/tay055. PMID: 30085265

Salzer HJH, Kuempers C, Pasternack H,  Heyckendorf J,  Bialek R,  Palade E,  Hundack L, Kalsdorf B,  Lange C. An unexpected endobronchial mass appearing during bronchoscopy. CHEST 2018; 154(1):e13-e21 PMID 30044749

Shah S, Lange C, Lonnroth K, Reflections on the “TB and Migration State-of-the-Art Series” and the Way Forward. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):829. doi: 10.5588/ijtld.18.0415. PMID 29991386

The Collaborative Group for the Analysis of Individual Patient Data in MDR-TB treatment. Members of the Group (in alphabetic order): Ahmad A, Ahuja SD, Akkerman OW, Alffenaar JWV, Anderson LF, Baghaei Shiva P, Bang D, Barry CE, Barry PM, Bastos ML, Behera DB, Benedetti A, Bisson GP, Boeree M, Bonnet M, Brode S, Brust JCM, Cai Y, Carlessso GF, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Chen R, Cirule A, D’Ambrosio L, de Vries G, Dheda K, Esmail A, Falzon D, Flood J, Fox G, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Frechet-Jachym M, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Liga Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Leimane V, Leung CC, Leung ECC, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Menzies D, Migliori GB, Milanov V, Miller AC, Mitnick C, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O’Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu T, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis– an individual patient data meta-analysis of 12,030 patients from 25 countries. The Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. PMID: 30215381

Ullmann A, Aguado JM, Arikan S, Denning D, Groll A; Lagrou K, Lass-Florl C, Lewis R, Muñoz P, Verweij P, Warris A, Akova M,  Arendrup MC,  Barnes R,  Blot S,  Bouza E, Brüggemann RJM, Buchheidt D,  Cadranel J,  Chakrabarti A, Cuenca-EstrellaM,  Dimopoulos G, Gangneux JP,  Garbino J,  Heinz W, Herbrecht R, Kibbler C, Klimko N,  Kullberg BJ,  Lange C,  Lehrnbecher T,  Loeffler J, Lortholary O,  Maertens J, Cornely O.Diagnosis and Management of Aspergillus Diseases: Executive Summary of the 2017 ESCMID-ECMM-ERS Guideline. Clin Microbiol Infect. 2018 Mar 12. pii: S1198-743X(18)30051-X. doi: 10.1016/j.cmi.2018.01.002. [Epub ahead of print]. PMID: 29544767

van Ingen J, Aksamit T Andréjak C, Böttger E, Cambau E, Daley C,  Griffith, DE, Guglielmetti L,  Holland S, Huitt G,  Koh WJ,  Lange C,  Leitman P,  Marras T,  Morimoto K, Olivier K, Santin M, Stout J, Rachel T,  Tortoli E, Wallace R,  Winthrop K,  Wagner D. Treatment outcome definitions in nontuberculous mycobacterial pulmonary disease – an NTM-NET consensus statement. Eur Respir J. 2018 Mar 22;51(3). pii: 1800170. doi: 10.1183/13993003.00170-2018. Print 2018 Mar. No abstract available. PMID: 29567726

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD van der Werf MJ, Kranzer, K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, van Soolingen D, Niemann S, Böttger E, Keller PM and the MDR-TB Cluster Consortium (Avsar K, Bauer C, Bernasconi E, Borroni E, Brusin S, Dévis MC, Crook DW, Dedicoat M, Fitzgibbon M, Gagneux S, Geiger F, Guthmann JP, Hendrickx D, Hoffmann-Thiel S, van Ingen J, Jackson S, Jaton K, Lange C, Mazza Stalder J, O'Donnell J, Opota P, Peto TEA, Preiswerk B, Roycroft E, Sato M, Schacher R, Schulthess B, E. Smith EG, Soini H, Sougakoff W, Tagliani E, Utpatel C, Veziris N, Wagner-Wiening C, Witschi M). A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study. Lancet Infect Dis. 2018 Jan 8. pii: S1473-3099(18)30004-5. doi: 10.1016/S1473-3099(18)30004-5. PMID: 29326013  (IF 25.1)

Zallet J, Olaru ID, Witt AK, Vock P, Kalsdorf B, Andres S, Hillemann D, Kranzer K. Evaluation of OMNIgene(®) SPUTUM reagent for mycobacterial culture. Int J Tuberc Lung Dis. 2018 Aug 1;22(8):945-949. doi: 10.5588/ijtld.17.0020. PMID: 29991406.

 

2017

Salzer, HJF, Lange, C & Hönigl, M 2017, 'Aspergillus-Nachweis im Atemwegsmaterial: Ignorieren oder behandeln?' Internist, Bd 58, Nr. 11, S. 1150-1162. DOI: 10.1007/s00108-017-0334-9

Miotto, P, Tessema, B, Tagliani, E, Chindelevitch, L, Starks, AM, Emerson, C, Hanna, D, Kim, PS, Liwski, R, Zignol, M, Gilpin, C, Niemann, S, Denkinger, CM, Fleming, J, Warren, RM, Crook, D, Posey, J, Gagneux, S, Hoffner, S, Rodrigues, C, Comas, I, Engelthaler, DM, Murray, M, Alland, D, Rigouts, L, Lange, C, Dheda, K, Hasan, R, Ranganathan, UDK, McNerney, R, Ezewudo, M, Cirillo, DM, Schito, M, Köser, CU & Rodwell, TC 2017, 'A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis' The European respiratory journal, Bd 50, Nr. 6. DOI: 10.1183/13993003.01354-2017

Salzer, HJF & Cornely, OA 2017, 'Awareness of predictors of mortality may help improve outcome in chronic pulmonary aspergillosis' The European respiratory journal, Bd 49, Nr. 2. DOI: 10.1183/13993003.02520-2016

Olaru, ID, Heyckendorf, J, Andres, S, Kalsdorf, B & Lange, C 2017, 'Bedaquiline-based treatment regimen for multidrug-resistant tuberculosis' The European respiratory journal, Bd 49, Nr. 5. DOI: 10.1183/13993003.00742-2017

Salzer, HJF, Heyckendorf, J, Kalsdorf, B, Rolling, T & Lange, C 2017, 'Characterization of patients with chronic pulmonary aspergillosis according to the new ESCMID/ERS/ECMM and IDSA guidelines' Mycoses, Bd 60, Nr. 2, S. 136-142. DOI: 10.1111/myc.12589

Dheda, K, Chang, KC, Guglielmetti, L, Furin, J, Schaaf, HS, Chesov, D, Esmail, A & Lange, C 2017, 'Clinical management of adults and children with MDR and XDR-TB' CLINICAL MICROBIOLOGY AND INFECTION , Bd 23, Nr. 3, S. 131-140. DOI: 10.1016/j.cmi.2016.10.008

Labugger, I, Heyckendorf, J, Dees, S, Häussinger, E, Herzmann, C, Kohl, TA, Richter, E, Rivera-Milla, E & Lange, C 2017, 'Detection of transrenal DNA for the diagnosis of pulmonary tuberculosis and treatment monitoring' INFECTION, Bd 45, Nr. 3, S. 269-276. DOI: 10.1007/s15010-016-0955-2

Bunjun, R, Riou, C, Soares, AP, Thawer, N, Müller, TL, Kiravu, A, Ginbot, Z, Oni, T, Goliath, R, Kalsdorf, B, von Groote-Bidlingmaier, F, Hanekom, W, Walzl, G, Wilkinson, RJ & Burgers, WA 2017, 'Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection' JOURNAL OF INFECTIOUS DISEASES, Bd 216, Nr. 12. DOI: 10.1093/infdis/jix529

Olaru, ID, McHugh, G, Dakshina, S, Majonga, E, Dauya, E, Bandason, T, Kranzer, K, Mujuru, H & Ferrand, RA 2017, 'False-negative HIV tests using oral fluid tests in children taking antiretroviral therapy from Harare, Zimbabwe' AIDS, Bd 20, Nr. Suppl 6, S. 21751. DOI: 10.7448/IAS.20.7.21751

Salzer, HJF, Rolling, T, Vinnemeier, CD, Tannich, E, Schmiedel, S, Addo, MM & Cramer, JP 2017, 'Helminthic infections in returning travelers and migrants with eosinophilia: Diagnostic value of medical history, eosinophil count and IgE' Travel medicine and infectious disease, Bd 20, S. 49-55. DOI: 10.1016/j.tmaid.2017.09.001

Chesov, D, Ciobanu, N, Lange, C, Heyckendorf, J & Crudu, V 2017, 'High-dose isoniazid in the shorter-course multidrug-resistant tuberculosis regimen in the Republic of Moldova' The European respiratory journal, Bd 50, Nr. 4. DOI: 10.1183/13993003.01340-2017

Allerberger, F, Cambau, E & Lange, C 2017, 'Joint efforts urgently needed at times of emerging tuberculosis drug resistance' CLINICAL MICROBIOLOGY AND INFECTION , Bd 23, Nr. 3, S. 129-130. DOI: 10.1016/j.cmi.2016.08.023

Chesov, D, Ciobanu, N, Lange, C, Schön, T, Heyckendorf, J & Crudu, V 2017, 'Lack of evidence of isoniazid efficacy for the treatment of MDR/XDR-TB in the presence of the katG 315T mutation' The European respiratory journal, Bd 50, Nr. 4. DOI: 10.1183/13993003.01752-2017

Nakiwala, D, Kellgren, L, Herzmann, C, Olaru, ID, Brown, M, Ferrand, RA, Khan, P & Kranzer, K 2017, 'Language discordance between tuberculosis patients and healthcare providers challenging universal access' The European respiratory journal, Bd 49, Nr. 4. DOI: 10.1183/13993003.00116-2017

Dudnyk, A, Butov, D, Crudu, V, Lange, C & Chesov, D 2017, 'MDR-TB in Eastern Europe in the era of the TB elimination action framework' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 21, Nr. 1, S. 2-3. DOI: 10.5588/ijtld.16.0732

Hargreaves, S, Lönnroth, K, Nellums, LB, Olaru, ID, Nathavitharana, RR, Norredam, M & Friedland, JS 2017, 'Multidrug-resistant tuberculosis and migration to Europe' CLINICAL MICROBIOLOGY AND INFECTION , Bd 23, Nr. 3, S. 141-146. DOI: 10.1016/j.cmi.2016.09.009

Heyckendorf, J, Brede, S, Guo, X, Haberl, B & Sayk, F 2017, 'Mutter und Sohn zwischen Allmacht und Koma' Medizinische Klinik, Intensivmedizin und Notfallmedizin, Bd 112, Nr. 6, doi: 10.1007/s00063-016-0238-9., S. pp 531–534. DOI: 10.1007/s00063-016-0238-9

Kodama, C, Lange, B, Olaru, ID, Khan, P, Lipman, M, Seddon, JA, Sloan, D, Grandjean, L, Ferrand, RA & Kranzer, K 2017, 'Mycobacterium tuberculosis transmission from patients with drug-resistant compared to drug-susceptible TB: a systematic review and meta-analysis' The European respiratory journal, Bd 50, Nr. 4. DOI: 10.1183/13993003.01044-2017

Munteanu, O & Salzer, HJF 2017, 'Non-Cystic Fibrosis Bronchiectasis: from Programmatic Management to Personalized Medicine' RESPIRATION, Bd 93, Nr. 6, S. 404-405. DOI: 10.1159/000473885

Bahmer, T, Waschki, B, Schatz, F, Herzmann, C, Zabel, P, Kirsten, A-M, Rabe, KF, Watz, H & ERA-Study Group 2017, 'Physical activity, airway resistance and small airway dysfunction in severe asthma' The European respiratory journal, Bd 49, Nr. 1, S. pii 1601827. DOI: 10.1183/13993003.01827-2016

van Ingen, J, Wagner, D, Gallagher, J, Morimoto, K, Lange, C, Haworth, CS, Floto, RA, Adjemian, J, Prevots, DR, Griffith, DE & NTM-NET 2017, 'Poor adherence to management guidelines in nontuberculous mycobacterial pulmonary diseases' The European respiratory journal, Bd 49, Nr. 2, S. pii 1601855. DOI: 10.1183/13993003.01855-2016

Herzmann, C, Ernst, M, Lange, C, Stenger, S, Kaufmann, SHE, Reiling, N, Schaberg, T, van der Merwe, L, Maertzdorf, J & Tb or not Tb consortium 2017, 'Pulmonary immune responses to Mycobacterium tuberculosis in exposed individuals' PLOS ONE, Bd 12, Nr. 11, S. e0187882. DOI: 10.1371/journal.pone.0187882

Herzmann, C, Golakov, M, Malekzada, F, Lonnroth, K & Kranzer, K 2017, 'Radiological screening of refugees in Germany' The European respiratory journal, Bd 49, Nr. 5. DOI: 10.1183/13993003.02487-2016

van Leth, F, Günther, G, Hoffmann, H, Lange, C & European MDR-TB database collaboration 2017, 'Reply from the Authors of Limited Benefit of the New Shorter MDR-TB Regimen in Europe' American journal of respiratory and critical care medicine, Bd 196, Nr. 11, S. 1489-1490. DOI: 10.1164/rccm.201705-0995LE

Schaberg, T, Bauer, T, Brinkmann, F, Diel, R, Feiterna-Sperling, C, Haas, W, Hartmann, P, Hauer, B, Heyckendorf, J, Lange, C, Nienhaus, A, Otto-Knapp, R, Priwitzer, M, Richter, E, Rumetshofer, R, Schenkel, K, Schoch, OD, Schönfeld, N & Stahlmann, R 2017, 'S2k-Leitlinie: Tuberkulose im Erwachsenenalter' Pneumologie (Stuttgart, Germany), Bd 71, Nr. 6, S. 325-397. DOI: 10.1055/s-0043-105954

Dheda, K, Gumbo, T, Maartens, G, Dooley, KE, McNerney, R, Murray, M, Furin, J, Nardell, EA, London, L, Lessem, E, Theron, G, van Helden, PD, Niemann, S, Merker, M, Dowdy, D, Van Rie, A, Siu, GKH, Pasipanodya, JG, Rodrigues, C, Clark, TG, Sirgel, FA, Esmail, A, Lin, H-H, Atre, SR, Schaaf, HS, Chang, K-C, Lange, C, Nahid, P, Udwadia, ZF, Horsburgh, CR, Churchyard, GJ, Menzies, D, Hesseling, AC, Nuermberger, E, McIlleron, H, Fennelly, KP, Goemaere, E, Jaramillo, E, Low, M, Jara, CM, Padayatchi, N & Warren, RM 2017, 'The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis' Lancet Respiratory Medicine. DOI: 10.1016/S2213-2600(17)30079-6

Silkoff, PE, Flavin, S, Gordon, R, Loza, MJ, Sterk, PJ, Lutter, R, Diamant, Z, Turner, RB, Lipworth, BJ, Proud, D, Singh, D, Eich, A, Backer, V, Gern, JE, Herzmann, C, Halperin, SA, Mensinga, TT, Del Vecchio, AM, Branigan, P, San Mateo, L, Baribaud, F, Barnathan, ES & Johnston, SL 2017, 'TLR3 Blockade in Rhinovirus-Induced Experimental Asthma Exacerbations: A Randomized Controlled Study' The Journal of allergy and clinical immunology. DOI: 10.1016/j.jaci.2017.06.027

Magis-Escurra, C, Günther, G, Lange, C, Alexandru, S, Altet, N, Avsar, K, Bang, D, Barbuta, R, Bothamley, GH, Ciobanu, A, Crudu, V, Davilovits, M, Dedicoat, M, Duarte, R, Gualano, G, Kunst, H, de Lange, WCM, Leimane, V, McLaughlin, A-M, Muylle, I, Polcová, V, Popa, C, Rumetshofer, R, Skrahina, A, Solodovnikova, V, Spinu, V, Tiberi, S, Viiklepp, P, van Leth, F & for TBnet 2017, 'Treatment outcomes of MDR-TB and HIV co-infection in Europe' The European respiratory journal, Bd 49, Nr. 6. DOI: 10.1183/13993003.02363-2016

Lönnroth, K, Mor, Z, Erkens, C, Bruchfeld, J, Nathavitharana, RR, van der Werf, MJ & Lange, C 2017, 'Tuberculosis in migrants in low-incidence countries: epidemiology and intervention entry points' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 21, Nr. 6, S. 624-637. DOI: 10.5588/ijtld.16.0845

Dedicoat, MJ, Günther, G, Crudu, V, Duarte, R, Gualano, G, Magis-Escurra, C, Rumetshofer, R, Skrahina, A, Spinu, V, Tiberi, S, Viiklepp, P, van Leth, F, Lange, C & TBNET 2017, 'Tuberculosis Treatment Outcomes in Europe: Based on Treatment Completion, Not Cure' American journal of respiratory and critical care medicine, Bd 196, Nr. 9, S. 1222-1224. DOI: 10.1164/rccm.201612-2585LE

Heyckendorf, J, Andres, S, Köser, CU, Olaru, ID, Schön, T, Sturegård, E, Beckert, P, Schleusener, V, Kohl, TA, Hillemann, D, Moradigaravand, D, Parkhill, J, Peacock, SJ, Niemann, S, Lange, C & Merker, M 2017, 'What is resistance?: Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy' ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. DOI: 10.1128/AAC.01550-17

 

2016

Günther, G, Lange, C, Alexandru, S, Altet, N, Avsar, K, Bang, D, Barbuta, R, Bothamley, G, Ciobanu, A, Crudu, V, Danilovits, M, Dedicoat, M, Duarte, R, Gualano, G, Kunst, H, de Lange, W, Leimane, V, Magis-Escurra, C, McLaughlin, A-M, Muylle, I, Polcová, V, Popa, C, Rumetshofer, R, Skrahina, A, Solodovnikova, V, Spinu, V, Tiberi, S, Viiklepp, P, van Leth, F & for TBNET 2016, 'Treatment Outcomes in Multidrug-Resistant Tuberculosis' New England Journal of Medicine, Bd 375, Nr. 11, S. 1103-5. DOI: 10.1056/NEJMc1603274

Salzer, HJF, Wassilew, N, Köhler, N, Olaru, ID, Günther, G, Herzmann, C, Kalsdorf, B, Sanchez-Carballo, P, Terhalle, E, Rolling, T, Lange, C & Heyckendorf, J 2016, 'Personalized Medicine for Chronic Respiratory Infectious Diseases: Tuberculosis, Nontuberculous Mycobacterial Pulmonary Diseases, and Chronic Pulmonary Aspergillosis' RESPIRATION, Bd 92, Nr. 4, S. 199-214. DOI: 10.1159/000449037

Busch, M, Herzmann, C, Kallert, S, Zimmermann, A, Höfer, C, Mayer, D, Zenk, SF, Muche, R, Lange, C, Bloom, BR, Modlin, RL, Stenger, S & TBornotTB Network 2016, 'Lipoarabinomannan-responsive Polycytotoxic T Cells are Associated With Protection in Human Tuberculosis' American journal of respiratory and critical care medicine, Bd 194, Nr. 3, S. 345-55. DOI: 10.1164/rccm.201509-1746OC

Olaru, ID, Lange, C, Indra, A, Meidlinger, L, Huhulescu, S & Rumetshofer, R 2016, 'High Rates of Treatment Success in Pulmonary Multidrug-Resistant Tuberculosis by Individually Tailored Treatment Regimens' Annals of the American Thoracic Society, Bd 13, Nr. 8, S. 1271-8. DOI: 10.1513/AnnalsATS.201512-845OC

Diacon, AH, van der Merwe, L, Barnard, M, von Groote-Bidlingmaier, F, Lange, C, García-Basteiro, AL, Sevene, E, Ballell, L & Barros-Aguirre, D 2016, 'β-Lactams against Tuberculosis--New Trick for an Old Dog?' New England Journal of Medicine, Bd 375, Nr. 4, S. 393-4. DOI: 10.1056/NEJMc1513236

Polverino, E, Bothamley, GH, Goletti, D, Heyckendorf, J, Sotgiu, G & Aliberti, S 2016, 'The best of respiratory infections from the 2015 European Respiratory Society International Congress' FEBS Open Bio, Bd 2, Nr. 3, S. 00049-2016. DOI: 10.1183/23120541.00049-2016

Griffith, DE & Lange, C 2016, 'When is a non-tuberculous mycobacterial infection a pulmonary disease?' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 20, Nr. 7, S. 855-6. DOI: 10.5588/ijtld.16.0243

Salzer, HJF, Terhalle, E & Lange, C 2016, 'Extensively drug-resistant tuberculosis in long-term travellers' Lancet Infectious Diseases, Bd 16, Nr. 6, S. 642-3. DOI: 10.1016/S1473-3099(16)30068-8

Krause, R, Halwachs, B, Thallinger, GG, Klymiuk, I, Gorkiewicz, G, Hoenigl, M, Prattes, J, Valentin, T, Heidrich, K, Buzina, W, Salzer, HJF, Rabensteiner, J, Prüller, F, Raggam, RB, Meinitzer, A, Moissl-Eichinger, C, Högenauer, C, Quehenberger, F, Kashofer, K & Zollner-Schwetz, I 2016, 'Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU Patients' PLOS ONE, Bd 11, Nr. 5, S. e0155033. DOI: 10.1371/journal.pone.0155033

DiNardo, AR, Lange, C & Mandalakas, AM 2016, '1,2,3 (years) …and your out. The End of a 123-year Historic Era' CLINICAL INFECTIOUS DISEASES , Bd 62, Nr. 9, S. 1089-91. DOI: 10.1093/cid/ciw041

Blauenfeldt, T, Wagner, D, Aabye, MG, Heyckendorf, J, Lange, B, Lange, C, Ernst, M, Ravn, P, Duarte, R, Morais, C, Hoffmann, M, Schoch, O, Dominguez, J, Latorre, I & Ruhwald, M 2016, 'Thermostability of IFN-g and IP-10 release assays for latent infection with Mycobacterium tuberculosis: A TBnet study: A TBnet study' Tuberculosis, Bd 98, Nr. 2016, Tuberculosis 98 (2016) 7e12, S. 7-12. DOI: 10.1016/j.tube.2015.04.013

Olaru, ID, Lange, C & Heyckendorf, J 2016, 'Personalized medicine for patients with MDR-TB' JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, Bd 71, Nr. 4, S. 852-5. DOI: 10.1093/jac/dkv354

Florea, D, Oţelea, D, Olaru, ID & Hristea, A 2016, 'Broad-range PCR coupled with mass-spectrometry for the detection of Mycobacterium tuberculosis drug resistance' Germs, Bd 6, Nr. 1, S. 10-3. DOI: 10.11599/germs.2016.1083

Merker, M, Crudu, V, Noroc, E, Romancenco, E, Chesov, D, Günther, G, Niemann, S & Lange, C 2016, 'In reply: The impact of mixed infections on the interpretation of molecular epidemiology studies of tuberculosis' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 20, Nr. 3, S. 424. DOI: 10.5588/ijtld.15.1024-2

Uyeki, TM, Mehta, AK, Davey, RT, Liddell, AM, Wolf, T, Vetter, P, Schmiedel, S, Grünewald, T, Jacobs, M, Arribas, JR, Evans, L, Hewlett, AL, Brantsaeter, AB, Ippolito, G, Rapp, C, Hoepelman, AIM, Gutman, J, Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and Europe & Salzer, HJF 2016, 'Clinical Management of Ebola Virus Disease in the United States and Europe' New England Journal of Medicine, Bd 374, Nr. 7, S. 636-46. DOI: 10.1056/NEJMoa1504874

Lange, C, van Leth, F, Sester, M & TBnet 2016, 'Viral Load and Risk of Tuberculosis in HIV Infection' JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, Bd 71, Nr. 2, S. e51-3. DOI: 10.1097/QAI.0000000000000834

Denning, DW, Cadranel, J, Beigelman-Aubry, C, Ader, F, Chakrabarti, A, Blot, S, Ullmann, AJ, Dimopoulos, G, Lange, C & European Society for Clinical Microbiology and Infectious Diseases and European Respiratory Society 2016, 'Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management' The European respiratory journal, Bd 47, Nr. 1, S. 45-68. DOI: 10.1183/13993003.00583-2015

Domínguez, J, Boettger, EC, Cirillo, D, Cobelens, F, Eisenach, KD, Gagneux, S, Hillemann, D, Horsburgh, R, Molina-Moya, B, Niemann, S, Tortoli, E, Whitelaw, A, Lange, C & TBNET and RESIST-TB networks 2016, 'Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET/RESIST-TB consensus statement' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 20, Nr. 1, S. 24-42. DOI: 10.5588/ijtld.15.0221

Salzer, HJF, Rolling, T, Schmiedel, S, Klupp, E-M, Lange, C & Seifert, H 2016, 'Severe Community-Acquired Bloodstream Infection with Acinetobacter ursingii in Person who Injects Drugs' EMERGING INFECTIOUS DISEASES, Bd 22, Nr. 1, S. 134-7. DOI: 10.3201/eid2201.151298

Wassilew, N, Hoffmann, H, Andrejak, C & Lange, C 2016, 'Pulmonary Disease Caused by Non-Tuberculous Mycobacteria' RESPIRATION, Bd 91, Nr. 5, S. 386-402. DOI: 10.1159/000445906

2015

Horsburgh, CR, Barry, CE & Lange, C 2015, 'Treatment of Tuberculosis' The New England Journal of Medicine, Bd 373, Nr. 22, S. 2149-60., 10.1056/NEJMra1413919

Sester M, van Crevel R, Leth Fv, Lange C. Numbers needed to treat to prevent tuberculosis. Eur Respir J. 2015 Dec;46(6):1836-8. doi: 10.1183/13993003.01047-2015.

Günther G, van Leth F, Altet N, Dedicoat M, Duarte R, Gualano G, Kunst H, Muylle I, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET. Beyond
multidrug-resistant tuberculosis in Europe: a TBNET study. Int J Tuberc Lung Dis. 2015 Dec;19(12):1524-7. doi: 10.5588/ijtld.15.0274.

Crudu V, Merker M, Lange C, Noroc E, Romancenco E, Chesov D, Günther G, Niemann S. Nosocomial transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2015 Dec;19(12):1520-3. doi: 10.5588/ijtld.15.0327.

Wassilew N, Lange C. Cure Not Possible, by Definition. Am J Respir Crit Care Med. 2015 Nov 15;192(10):1255-6. doi: 10.1164/rccm.201507-1392LE.

Olaru ID, Lange C, Heyckendorf J. Personalized medicine for patients with MDR-TB. J Antimicrob Chemother. 2015 Oct 27. pii: dkv354. [Epub ahead of print] Review.

Kalsdorf B, Olaru ID, Lange C, Heyckendorf J. [Tuberculosis]. Dtsch Med Wochenschr. 2015 Oct;140(20):1508-12. doi: 10.1055/s-0041-105904. Epub 2015 Oct 7.

Olaru ID, Lange C, Sester M. Revisiting Healthcare Workers as a Risk Group for Progression toward Tuberculosis. Am J Respir Crit Care Med. 2015 Oct 15;192(8):1021-2. doi: 10.1164/rccm.201506-1192LE.

Parida SK, Poiret T, Zhenjiang L, Meng Q, Heyckendorf J, Lange C, Ambati AS, Rao MV, Valentini D, Ferrara G, Rangelova E, Dodoo E, Zumla A, Maeurer M. T-Cell  Therapy: Options for Infectious Diseases. Clin Infect Dis. 2015 Oct 15;61Suppl 3:S217-24. doi: 10.1093/cid/civ615.

Dedicoat M, Lange C. Tuberculosis preventive chemotherapy: the times they are  a-changin'. Int J Tuberc Lung Dis. 2015 Sep;19(9):1002. doi: 10.5588/ijtld.15.0599.

Dudnyk A, Rzhepishevska O, Rogach K, Kutsyna G, Lange C. Multidrug-resistant  tuberculosis in Ukraine at a time of military conflict. Int J Tuberc Lung Dis. 2015 Apr;19(4):492-3. doi: 10.5588/ijtld.14.0940.

Herzmann C, Sotgiu G, Schaberg T, Ernst M, Stenger S, Lange C; TB or not TB Consortium. Childhood BCG vaccination does not influence control of Mycobacterium tuberculosis growth by human bronchoalveolar lavage cells. Tuberculosis (Edinb).  2015 May;95(3):321-7. doi: 10.1016/j.tube.2015.02.044. Epub 2015 Feb 28.

Chesov D, Lange C, Daduna F, Crudu V, Preyer R, Ernst M, Kalsdorf B. Combined antigen-specific interferon-γ and interleukin-2 release assay (FluoroSpot) for the diagnosis of Mycobacterium tuberculosis infection. PLoS One. 2015 Mar 18;10(3):e0120006. doi: 10.1371/journal.pone.0120006. eCollection 2015.

Zellweger JP, Sotgiu G, Block M, Dore S, Altet N, Blunschi R, Bogyi M, Bothamley G, Bothe C, Codecasa L, Costa P, Dominguez J, Duarte R, Fløe A, Fresard I, García-García JM, Goletti D, Halm P, Hellwig D, Henninger E, Heykes-Uden H, Horn L, Kruczak K, Latorre I, Pache G, Rath H, Ringshausen FC, Ruiz AS, Solovic I, Souza-Galvão ML, Widmer U, Witte P, Lange C; TBNET. Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study. Am J Respir Crit Care Med. 2015 May 15;191(10):1176-84. doi:  10.1164/rccm.201502-0232OC.

Günther G, van Leth F, Alexandru S, Altet N, Avsar K, Bang D, Barbuta R, Bothamley G, Ciobanu A, Crudu V, Davilovits M, Dedicoat M, Duarte R, Gualano G, Kunst H, de Lange W, Leimane V, Magis-Escurra C, McLaughlin AM, Muylle I, Polcová V, Pontali E, Popa C, Rumetshofer R, Skrahina A, Solodovnikova V, Spinu V, Tiberi S, Viiklepp P, Lange C; TBNET. Multidrug-resistant tuberculosis in Europe, 2010-2011. Emerg Infect Dis. 2015 Mar;21(3):409-16. doi: 10.3201/eid2103.141343.

Olaru ID, Rachow A, Lange C, Ntinginya NE, Reither K, Hoelscher M, Vollrath O, Niemann S. Ascertaining in vivo virulence of Mycobacterium tuberculosis lineages in patients in Mbeya, Tanzania. Int J Tuberc Lung Dis. 2015 Jan;19(1):70-3. doi: 10.5588/ijtld.14.0403. PubMed PMID: 25519793.

Günther G, Gomez GB, Lange C, Rupert S, van Leth F; TBNET. Availability, price and affordability of anti-tuberculosis drugs in Europe: a TBNET survey. Eur Respir J. 2015 Apr;45(4):1081-8. doi: 10.1183/09031936.00124614. Epub 2014 Nov 13.

Dudnyk, A, Rzhepishevska, O, Rogach, K, Kutsyna, G & Lange, C 2015, 'Multidrug-resistant tuberculosis in Ukraine at a time of military conflict' INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, Bd 19, Nr. 4, S. 492-3.

Günther, G, Gomez, GB, Lange, C, Rupert, S, van Leth, F & on behalf of the TBNET 2015, 'Availability, price and affordability of anti-tuberculosis drugs in Europe: A TBNET survey' The European respiratory journal, Bd 45, Nr. 4, S. 1081-8.

Olaru, ID, von Groote-Bidlingmaier, F, Heyckendorf, J, Yew, WW, Lange, C & Chang, KC 2015, 'Novel drugs against tuberculosis: a clinician's perspective' The European respiratory journal, Bd 45, Nr. 4, S. 1119-31.

Chesov, D, Lange, C, Daduna, F, Crudu, V, Preyer, R, Ernst, M & Kalsdorf, B 2015, 'Combined Antigen-Specific Interferon-γ and Interleukin-2 Release Assay (FluoroSpot) for the Diagnosis of Mycobacterium tuberculosis Infection' PLOS ONE, Bd 10, Nr. 3, S. e0120006.

Zellweger, J-P, Sotgiu, G, Block, M, Dore, S, Altet, N, Blunschi, R, Bogyi, M, Bothamley, G, Bothe, C, Codecasa, L, Costa, P, Dominguez, J, Duarte, R, Fløe, A, Fresard, I, García-García, J-M, Goletti, D, Halm, P, Hellwig, D, Henninger, E, Heykes-Uden, H, Horn, L, Kruczak, K, Latorre, I, Pache, G, Rath, H, Ringshausen, FC, Seminario Ruiz, A, Solovic, I, de Souza-Galvão, M-L, Widmer, U, Witte, P, Lange, C & TBNET 2015, 'Risk Assessment of Tuberculosis in Contacts by Interferon-γ Release Assays (IGRAs). A TBNET Study' American journal of respiratory and critical care medicine, Bd 191, Nr. 10, S. 1176-84.

Hristea, A, Olaru, ID, Adams-Sapper, S, Riley, LW & Lange, C 2015, 'Characterization of ESBL-producing Escherichia coli and Klebsiella pneumoniae from bloodstream infections in three hospitals in Bucharest, Romania: a preliminary study' SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES , Bd 47, Nr. 1, S. 46-51.

de Visser, V, Sotgiu, G, Lange, C, Aabye, MG, Bakker, M, Bartalesi, F, Brat, K, Chee, CBE, Dheda, K, Dominguez, J, Eyuboglu, F, Ghanem, M, Goletti, D, Dilektasli, AG, Guglielmetti, L, Koh, W-J, Latorre, I, Losi, M, Polanova, M, Ravn, P, Ringshausen, FC, Rumetshofer, R, de Souza-Galvão, ML, Thijsen, S, Bothamley, G, Bossink, A & for the TBNET 2015, 'False-negative interferon-γ release assay results in active tuberculosis: a TBNET study' The European respiratory journal, Bd 45, Nr. 1, S. 279-83.

 

2014

Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Gorek Dilektasli A et al. Risk Assessment of Tuberculosis in Immunocompromised Patients - A TBNET Study. American journal of respiratory and critical care medicine. 2014 Nov 15;190(20):1168-1176.

Bastos ML, Hussain H, Weyer K, Garcia-Garcia L, Leimane V, Leung CC et al. Treatment Outcomes of Patients With Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis According to Drug Susceptibility Testing to First- and Second-line Drugs: An Individual Patient Data Meta-analysis. CLINICAL INFECTIOUS DISEASES . 2014 Nov 5;59(10):1364-74.

Lange C. M/XDR-tuberculosis therapy as prevention. Drug Research. 2014 Nov 1;64 Suppl 1:S24.

Kalsdorf B, Lange C. Prednisolon oder Mykobakterien-Therapie bei tuberkulöser Perikarditis? - Nur Prednisolon bringt Therapiezugewinn. Deutsche medizinische Wochenschrift (1946). 2014 Nov 1;139(48):2438.

Lange C, Kampmann B. Preventive chemotherapy for contacts of MDR-TB: is the proof in the pudding?. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2014 Nov 1;18(11):1262-3.

Herzmann C, Sotgiu G, Schaberg T, Ernst M, Stenger S, Lange C et al. Early BCG vaccination is unrelated to pulmonary immunity against Mycobacterium tuberculosis in adults. The European respiratory journal. 2014 Okt;44(4):1087-90.

Heyckendorf J, Olaru ID, Ruhwald M, Lange C. Getting personal Perspectives on individualized treatment duration in M/XDR-TB. American journal of respiratory and critical care medicine. 2014 Aug 15;190(4):374-383.

Lange C, Abubakar I, Alffenaar J-WC, Bothamley G, Caminero JA, Carvalho ACC et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. The European respiratory journal. 2014 Jul;44(1):23-63.

Yew W-W, Lange C. Linezolid in the treatment of drug-resistant tuberculosis the way forward?. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2014 Jun 1;18(6):631-2.

Günther G. Multidrug-resistant and extensively drug-resistant tuberculosis a review of current concepts and future challenges. CLINICAL MEDICINE . 2014 Jun 1;14(3):279-85.

Kaufmann SHE, Lange C, Rao M, Balaji KN, Lotze M, Schito M et al. Progress in tuberculosis vaccine development and host-directed therapies-a state of the art review. Lancet Respiratory Medicine. 2014 Apr 1;2(4):301-320.

Munteanu O, Chesov D, Rusu D, Lange C, Botnaru V. Pulmonary Erythema Migrans?. RESPIRATION. 2014 Jan 14;87(3):252-3.

Gutsfeld C, Olaru ID, Vollrath O, Lange C. Attitudes about Tuberculosis Prevention in the Elimination Phase: A Survey among Physicians in Germany. PLOS ONE. 2014 Jan 1;9(11):e112681.

Essone PN, Kalsdorf B, Chegou NN, Loxton AG, Kriel M, Preyer R et al. Bifunctional T-cell-derived cytokines for the diagnosis of tuberculosis and treatment monitoring. RESPIRATION. 2014 Jan 1;88(3):251-61.

Blauenfeldt T, Heyckendorf J, Graff Jensen S, Lange C, Drabe C, Hermansen TS et al. Development of a One-Step Probe Based Molecular Assay for Rapid Immunodiagnosis of Infection with M. tuberculosis Using Dried Blood Spots. PLOS ONE. 2014 Jan 1;9(9):e105628.

Yew W-W, Lange C. Fluoroquinolone resistance in Mycobacterium tuberculosis. What have we learnt? [Editorial]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2014 Jan 1;18(1):1-2.

Olaru ID, Heyckendorf J, Grossmann S, Lange C. Time to Culture Positivity and Sputum Smear Microscopy during Tuberculosis Therapy. PLOS ONE. 2014 Jan 1;9(8):e106075.

Chegou NN, Heyckendorf J, Walzl G, Lange C, Ruhwald M. Beyond the IFN-γ horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis. The European respiratory journal. 2014;43(5):1472-86.

 

2013

Jafari C, Ernst M, Kalsdorf B, Lange C. Comparison of molecular and immunological methods for the rapid diagnosis of smear-negative tuberculosis. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE. 2013 Nov 1;17(11):1459-65.

Dalhoff K, Ewig S, Abele-Horn M, Andreas S, Bauer TT, von Baum H et al. Adult patients with nosocomial pneumonia epidemiology, diagnosis, and treatment. Deutsches Ärzteblatt International. 2013 Sep 1;110(38):634-40.

Thoden J, Potthoff A, Bogner JR, Brockmeyer NH, Esser S, Grabmeier-Pfistershammer K et al. Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066). INFECTION. 2013 Sep 1;41 Suppl 2:91-115.

Leung CC, Lange C, Zhang Y. Tuberculosis: Current state of knowledge: An Epilogue. RESPIROLOGY 2013 Oct;18(7):1047-55.

Migliori GB, Sotgiu G, Gandhi NR, Falzon D, DeRiemer K, Centis R et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. The European respiratory journal. 2013 Jul 1;42(1):169-79.

Liang F, Bond E, Sandgren KJ, Smed-Sörensen A, Rangaka MX, Lange C et al. Dendritic cell recruitment in response to skin antigen tests in HIV-1-infected individuals correlates with the level of T-cell infiltration. AIDS. 2013 Apr 24;27(7):1071-80.

Chee CB-E, Sester M, Zhang W, Lange C. Diagnosis and treatment of latent infection with Mycobacterium tuberculosis. RESPIROLOGY. 2013 Feb 1;18(2):205-16.

Kalsdorf B, Skolimowska KH, Scriba TJ, Dawson R, Dheda K, Wood K et al. Relationship between chemokine receptor expression, chemokine levels and HIV-1 replication in the lungs of persons exposed to Mycobacterium tuberculosis. European journal of immunology. 2013 Feb 1;43(2):540-9.

Reiling N, Homolka S, Walter K, Brandenburg J, Niwinski L, Ernst M et al. Clade-Specific Virulence Patterns of Mycobacterium tuberculosis Complex Strains in Human Primary Macrophages and Aerogenically Infected Mice. mBio. 2013 Jan 1;4(4).

Pitigoi D, Olaru ID, Badescu D, Rafila A, Arama V, Hristea A et al. Mediterranean spotted fever in southeastern Romania. BioMed Research International. 2013 Jan 1;2013:395806.